Intestinal microbiome and myelodysplastic syndromes: Current state of knowledge and perspectives for future

被引:1
作者
Simunic, Marin [1 ,2 ,3 ]
Mcgraw, Kathy [1 ,2 ]
Pavletic, Steven Z. [1 ,2 ]
Rashidi, Armin [4 ]
机构
[1] NCI, Immune Deficiency Cellular Therapy Program ID CTP, NIH, Bethesda, MD USA
[2] NCI, Myeloid Malignancies Program, NIH, Bethesda, MD USA
[3] Clin Hosp Ctr, Dept Hematol, Clin Internal Med, Split, Croatia
[4] Fred Hutchinson Canc Res Ctr, Clin Res Div, 1100 Fairview Ave N,Thomas Bldg, Seattle, WA 98109 USA
基金
美国国家卫生研究院;
关键词
MDS; Intestinal; Microbiome; ARYL-HYDROCARBON RECEPTOR; GUT MICROBIOTA; CANCER; METABOLISM; MODULATION; TRYPTOPHAN; DOMINATION; HIPPURATE; BACTERIAL; IMMUNITY;
D O I
10.1053/j.seminhematol.2024.10.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The intestinal microbiome has been mechanistically linked with health and many disease processes. Cancer is no exception. Both in solid tumors and hematologic malignancies, there is increasing evidence supporting the involvement of the intestinal microbiome in tumor development, disease progression, response to treatment, and treatment toxicity. Consistent with microbiome mediation of the immune system and the potent effect of the immune system on cancer, the most compelling evidence has been obtained in the setting of cancer immunotherapy. Here, we review the current state of knowledge about microbiome effects in myelodysplastic syndromes, identify gaps and challenges in related research, and provide insights for future work. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:442 / 448
页数:7
相关论文
共 50 条
[11]   The Current and Future State of Microbiome Therapeutics in Liver Disease [J].
Bloom, Patricia P. ;
Bajaj, Jasmohan S. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (1S) :S36-S41
[12]   The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions [J].
Troseid, Marius ;
Andersen, Geir Oystein ;
Broch, Kaspar ;
Hov, Johannes Roksund .
EBIOMEDICINE, 2020, 52
[13]   Application of immunostimulants in aquaculture: current knowledge and future perspectives [J].
Wang, Wei ;
Sun, Jing ;
Liu, Cenjie ;
Xue, Zhuang .
AQUACULTURE RESEARCH, 2017, 48 (01) :1-23
[14]   Current knowledge and future perspectives in breast surgery: an overview [J].
Nava, Maurizio B. ;
Catanuto, Giuseppe ;
Rocco, Nicola .
MINERVA CHIRURGICA, 2018, 73 (03) :295-296
[15]   The Emerging Role of the Gut Microbiome in Cardiovascular Disease: Current Knowledge and Perspectives [J].
Papadopoulos, Panagiotis D. ;
Tsigalou, Christina ;
Valsamaki, Pipitsa N. ;
Konstantinidis, Theocharis G. ;
Voidarou, Chrysoula ;
Bezirtzoglou, Eugenia .
BIOMEDICINES, 2022, 10 (05)
[16]   Diabetes Management by Probiotics: Current Knowledge and Future Perspectives [J].
Homayouni-Rad, Aziz ;
Soroush, Ahmad-Reza ;
Khalili, Leila ;
Norouzi-Panahi, Leila ;
Kasaie, Zahra ;
Ejtahed, Hanieh-Sadat .
INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 2016, 86 (5-6) :215-227
[17]   Personalized Dietary Regimens for Inflammatory Bowel Disease: Current Knowledge and Future Perspectives [J].
Wellens, Judith ;
Vissers, Eva ;
Matthys, Christophe ;
Vermeire, Severine ;
Sabino, Joao .
PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2023, 16 :15-27
[18]   Somatic mosaicism in inborn errors of immunity: Current knowledge, challenges, and future perspectives [J].
Aluri, Jahnavi ;
Cooper, Megan A. .
SEMINARS IN IMMUNOLOGY, 2023, 67
[19]   The Role of the Microbiome in Cancer Therapies Current Evidence and Future Directions [J].
Chalif, Julia ;
Goldstein, Naomi ;
Mehra, Yogita ;
Spakowicz, Dan ;
Chambers, Laura M. .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2025, 39 (02) :269-294
[20]   The Role of the Gut Microbiome in Cancer Immunotherapy: Current Knowledge and Future Directions [J].
Kiousi, Despoina E. ;
Kouroutzidou, Antonia Z. ;
Neanidis, Konstantinos ;
Karavanis, Emmanuel ;
Matthaios, Dimitrios ;
Pappa, Aglaia ;
Galanis, Alex .
CANCERS, 2023, 15 (07)